Literature DB >> 29976076

Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases.

Gilbert Akankwasa1, Liu Jianhua1, Cheng Guixue1, An Changjuan1, Qin Xiaosong1.   

Abstract

Urinary podocalyxin and nephrin are urine markers of podocyte dysfunction that may reflect the integrity of kidney's filtration barrier. Studies on their respective roles in glomerular diseases are still underway. However, the isolated and unsystematic manner in which they are being studied does not permit proper identification of their roles in each glomerular disease. As such, there is little or no appreciation of what research has already achieved and what remains to be achieved as the research direction is not clearly defined. We explored the recent studies and outlined the major findings regarding the value of both biomarkers in each of the three glomerular disease entities. Our review covered diabetic nephropathy, membranous nephropathy and IgA nephropathy.

Entities:  

Keywords:  IgA nephropathy; biomarkers; diabetic nephropathy membranous nephropathy; diaphragm; endothelium; markers; nephrin; podocalyxin; podocyte; proteinuria

Mesh:

Substances:

Year:  2018        PMID: 29976076     DOI: 10.2217/bmm-2018-0152

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  7 in total

1.  Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression.

Authors:  Mona K Tawfik; Mohammed M Keshawy; Samy Makary
Journal:  Mol Biol Rep       Date:  2021-08-24       Impact factor: 2.316

2.  PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway.

Authors:  Zhihong Lu; Xiujuan Zhu; Yuhong Ye; Haidong Fu; Jianhua Mao
Journal:  Cytotechnology       Date:  2021-08-13       Impact factor: 2.040

3.  First Whole Transcriptome RNAseq on CHD8 Haploinsufficient Patient and Meta-Analyses Across Cellular Models Uncovers Likely Key Pathophysiological Target Genes.

Authors:  Heba Yasin; Robert Stowe; Chi Kin Wong; Puthen Veettil Jithesh; Farah R Zahir
Journal:  Cureus       Date:  2020-11-19

Review 4.  Emerging Biomarkers for Early Detection of Chronic Kidney Disease.

Authors:  Maja Mizdrak; Marko Kumrić; Tina Tičinović Kurir; Joško Božić
Journal:  J Pers Med       Date:  2022-03-31

5.  Ameliorative Effects of Bredemolic Acid on Markers Associated with Renal Dysfunction in a Diet-Induced Prediabetic Rat Model.

Authors:  Akinjide Moses Akinnuga; Angezwa Siboto; Bongiwe Khumalo; Ntethelelo Hopewell Sibiya; Phikelelani Ngubane; Andile Khathi
Journal:  Oxid Med Cell Longev       Date:  2020-06-22       Impact factor: 6.543

6.  Association between Renal Podocalyxin Expression and Renal Dysfunction in Patients with Diabetic Nephropathy: A Single-Center, Retrospective Case-Control Study.

Authors:  Rongzhen Wang; Can Yao; Feng Liu
Journal:  Biomed Res Int       Date:  2020-04-03       Impact factor: 3.411

7.  Increased Endocytosis of Cadmium-Metallothionein through the 24p3 Receptor in an In Vivo Model with Reduced Proximal Tubular Activity.

Authors:  Itzel Pamela Zavala-Guevara; Manolo Sibael Ortega-Romero; Juana Narváez-Morales; Tania Libertad Jacobo-Estrada; Wing-Kee Lee; Laura Arreola-Mendoza; Frank Thévenod; Olivier Christophe Barbier
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.